Patients′ characteristics (n=56)
| Parameter | Category | No. of analyzed patients (% of total) |
| Age, years | <30 | 2 (3.6%) |
| 30–40 | 8 (14.3%) | |
| 40–50 | 17 (30.4%) | |
| 50–60 | 17 (30.4%) | |
| 60–70 | 11 (19.6%) | |
| >70 | 1 (1.8%) | |
| Grading | G1 | 0 (0.0%) |
| G2 | 11 (19.6%) | |
| G3 | 45 (80.4%) | |
| Nodal status | cN0 | 40 (71.4%) |
| cN1 | 13 (23.2%) | |
| cN2 | 1 (1.8%) | |
| cN3 | 2 (3.6)% | |
| Tumor size | cT1 | 23 (41.1%) |
| cT2 | 32 (57.1%) | |
| cT3 | 1 (1.8%) | |
| cT4 | 0 (0.0%) | |
| Stromal TILs | 0%–10% | 20 (35.7%) |
| 11%–59% | 28 (50.0%) | |
| ≥60% | 8 (14.3%) | |
| Parameter | Measure | Value |
| Ki67 | Mean±SD | 50.0±19.4 |
| Min, median, max | 9–48–92 | |
| Stromal TILs | Mean±SD | 24.4±21.1 |
| Min, median, max | 0–17–80 |
TIL, tumor infiltrating lymphocyte.